Skip to main content
Rase AI Intelligence Newsletter

Healthcare, biotechnology & medical AI Product

ThinkSono Guidance assists with acquiring vascular ultrasound images

ThinkSono Guidance provides live image-acquisition guidance for a specified lower-limb vascular ultrasound workflow related to suspected deep vein thrombosis. [1]

Release status
U.S. FDA 510(k) clearance K260338, decided July 15, 2026. [1]

What it does

The FDA cleared ThinkSono Guidance under K260338 on July 15, 2026, as Class II AI-guided image acquisition software. [1]

Why it matters

The decision defines the software’s role at the image-acquisition stage. It distinguishes guidance while collecting images from interpreting the resulting examination. [1]

Who it’s for

The labeling describes healthcare professionals without prior ultrasound training as operators and qualified clinicians as image reviewers. [1]

Key dates

  1. FDA clears ThinkSono Guidance [1]

Where it fits

The software is an accessory to compatible handheld point-of-care ultrasound systems and supports acquisition for later professional interpretation. [1]

Limits and trade-offs

The clearance is limited to the acquisition role and the indicated vascular imaging workflow. Clinical interpretation remains a separate task. [1]

Sources and verification

Catalog evidence checked How we verify records

  1. Primary source FDA 510(k) decision K260338: ThinkSono Guidance
  2. Primary source ThinkSono newsroom

Related profiles

Healthcare, biotechnology & medical AI

Sleep Analysis Module (SAM)

Neurotronics (Nihon Kohden)

The module estimates sleep time from a signal captured during its intended sleep-testing workflow.

High confidenceEvidence checked

Healthcare, biotechnology & medical AI

Heartvue.Proton

Heartvue.ai

It is software for analyzing cardiac MRI images within its documented intended-use scope.

Medium confidenceEvidence checked

Healthcare, biotechnology & medical AI

Methinks Stroke suite

Methinks AI

Provides radiology triage and notification software, with separate FDA decisions for Methinks NCCT Stroke and CTA Stroke.

High confidenceEvidence checked